Donate
|
Join/Renew
|
Store
|
View Cart
|
Log In
|
Create Account
Search SNMMI.org
Search SNMMI Learning Center
Value Initiative
|
Physicians
|
Technologists
|
Scientists
|
Residents
|
Healthcare Provider
|
Patients
NEWS & PUBLICATIONS
News
Newsletters
Journals
Books
MEMBERSHIP
Join/Renew
Benefits
Categories
Membership Directory
Chapters
Centers of Excellence
Councils
EDUCATION
MEETINGS & EVENTS
Calendar of Events
Annual Meeting
Mid-Winter Meeting
AACR-SNMMI 2015 Joint Conference
Nuclear Medicine & Molecular Imaging Week
Roadshows
SNMMI-TS Leadership Academy
Webinars
NCI-SNMMI Workshop on Targeted Radionuclide Therapy
ISSUES & ADVOCACY
Legislative Issues & Priorities
Regulatory Issues & Priorities
Grassroots Issues
Position Statements
Coalition for PET Drug Approval
HPRA Newsletter
Government Relations News
QUALITY & PRACTICE
Guidance
Quality
Practice Resources
Coding & Reimbursement
About Quality & Practice
Dose Optimization
RESEARCH
Clinical Trials Network
Preclinical Imaging
Nuclear Medicine Clinical Trial Group, LLC
Research Learn More
ABOUT SNMMI
Strategic Plan
Bylaws & Procedures
Governance-SNMMI
Governance - SNMMI-TS
History
Grants, Awards, and Scholarships
Annual Reports
Career Center
New in Profession
About Nuclear Medicine & Molecular Imaging
Outreach
Support SNMMI
HOME
>
ISSUES & ADVOCACY
In This Section
Legislative Issues & Priorities
Regulatory Issues & Priorities
Grassroots Issues
State TAG Team
How to be a Grassroots Advocate
Position Statements
Coalition for PET Drug Approval
HPRA Newsletter
Government Relations News
Advertisement
Position Statements
Medicare Sustainable Growth Rate (SGR) Formula
Radiopharmaceutical Reimbursement Policy Statement
Dose Optimization Policy Statement
FDA Radiation Reduction Program Policy Statement
Use of Compounded Radiopharmaceuticals and Adjunct Drug Preparations Policy Statement
Joint Statement on Radioactive Precautions Following Radioactive Iodine Therapy Policy Statement
Beyond-Use Dates (BUD) for Tc-99m Policy Statement
Joint Statement on Japan Crisis and Radioactive Iodine
Domestic Isotope Availability Policy Statement
Conditions of Participation/Direct Supervision Policy Statement
Nuclear Medicine Research Funding Policy Statement
Technologist Credentialing/CARE Act Policy Statement
RELATED CONTENT
Nuclear Medicine and Molecular Imaging Week: October 5-11, 2014
Frequently Asked Questions
Dose Optimization: Additional links
Appropriate Use Criteria
Legislative Issues